Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lulu Liu, Haihui Liu, Lei Liu, Qian Huang, Chunyan Yang, Panpan Cheng, Saisai Ren, Jingjing Zhang, Mingxiao Yu, Xinying Ma, Wenjun Song, Lulu Chen, Hao Zhang, Mingtai Chen & Xianning Zhang. (2023) Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression. Cancer Biology & Therapy 24:1.
Read now
Read now
Yi Chen, Jing Cao, Yaozhen Ye, Luting Luo, Xiaoyun Zheng, Xiaozhu Yang, Zhihong Zheng, Jing Zheng, Ting Yang & Jianda Hu. (2023) Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience. Journal of Chemotherapy 35:4, pages 322-329.
Read now
Read now
Jun Li & Xiaoping Yin. (2022) Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the treatment of acute myeloid leukemia: a systematic meta-analysis. Hematology 27:1, pages 300-309.
Read now
Read now
Elisabetta Abruzzese & Pasquale Niscola. (2020) Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms. Expert Review of Hematology 13:12, pages 1349-1359.
Read now
Read now
Raffaele Palmieri, Sarah A. Buckley, Megan Othus, Anna B. Halpern, Mary-Elizabeth M. Percival, Bart L. Scott, Paul C. Hendrie, Pamela S. Becker, Vivian G. Oehler, Elihu H. Estey & Roland B. Walter. (2020) Randomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm. Leukemia & Lymphoma 61:7, pages 1728-1731.
Read now
Read now